Locoregional recurrence after curative intent resection for intrahepatic cholangiocarcinoma: implications for adjuvant radiotherapy

被引:18
作者
Song, S. [1 ]
Kim, K. [1 ]
Chie, E. K. [1 ,3 ]
Kim, S. [1 ]
Park, H. J. [1 ]
Yi, N. J. [2 ]
Suh, K. -S. [2 ]
Ha, S. W. [1 ,3 ]
机构
[1] Seoul Natl Univ, Coll Med, Dept Radiat Oncol, Seoul 110744, South Korea
[2] Seoul Natl Univ, Coll Med, Dept Surg, Seoul, South Korea
[3] Seoul Natl Univ, Med Res Ctr, Inst Radiat Med, Seoul, South Korea
关键词
Intrahepatic cholangiocarcinoma; Surgery; Locoregional recurrence; Radiotherapy; RADIATION-THERAPY; IMPROVED SURVIVAL; LIVER-RESECTION; MANAGEMENT; PATHOGENESIS;
D O I
10.1007/s12094-015-1312-0
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
As for intrahepatic cholangiocarcinoma, the most frequent site of failure after curative intent resection is the liver. We identified the risk factors for locoregional recurrence after curative intent resection for intrahepatic cholangiocarcinoma. Medical records of 115 patients treated with surgical resection alone for intrahepatic cholangiocarcinoma from November 2000 to December 2010 were retrospectively reviewed. Locoregional failure was defined as recurrence within 20 mm from resection margin or regional lymph node. Overall survival and locoregional recurrence rates were analyzed using Kaplan-Meier methods, and the prognostic factors were analyzed using Cox proportional hazards model. Median follow-up duration of surviving patients was 61 months (range 8-139). Sixty-six patients had recurrence, and 45 of 66 patients (68 %) had locoregional recurrence. The 5-year overall survival and locoregional control rates were 49.1 and 51.6 %, respectively. a parts per thousand yenT2b disease and R1 resection were associated with locoregional recurrence in multivariate analysis. Patients were divided into two groups whether these risk factors exist or not. The 5-year locoregional control rates of low (no risk factor n = 64) and high (1 or 2 risk factors n = 51) risk groups were 62.5 and 34.7 %, respectively (P = 0.001). After curative intent resection, locoregional control and survival of patients with intrahepatic cholangiocarcinoma were far from satisfactory. Further studies are needed to evaluate the potential benefit of adjuvant locoregional treatment such as radiotherapy for patients with high-risk factors (a parts per thousand yenT2b disease or R1 resection).
引用
收藏
页码:825 / 829
页数:5
相关论文
共 21 条
[1]  
[Anonymous], 2015, AJCC Cancer Staging Manual
[2]   Phase II trial of high-dose conformal radiation therapy with concurrent hepatic artery floxuridine for unresectable intrahepatic malignancies [J].
Ben-Josef, E ;
Normalle, D ;
Ensminger, WD ;
Walker, S ;
Tatro, D ;
Ten Haken, RK ;
Knol, J ;
Dawson, LA ;
Pan, C ;
Lawrence, TS .
JOURNAL OF CLINICAL ONCOLOGY, 2005, 23 (34) :8739-8747
[3]   DOES ADJUVANT RADIOTHERAPY SUPPRESS LIVER REGENERATION AFTER PARTIAL HEPATECTOMY? [J].
Choi, Jin-Hwa ;
Kim, Kyubo ;
Chie, Eui Kyu ;
Jang, Jin-Young ;
Kim, Sun Whe ;
Oh, Do-Youn ;
Im, Seock-Ah ;
Kim, Tae-You ;
Bang, Yung-Jue ;
Ha, Sung W. .
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2009, 74 (01) :67-72
[4]   Intrahepatic cholangiocardnoma - Rising frequency, improved survival, and determinants of outcome after resection [J].
Endo, Itaru ;
Gonen, Mithat ;
Yopp, Adam C. ;
Dalal, Kimberly M. ;
Zhou, Qin ;
Klimstra, David ;
DAngelica, Michael ;
DeMatteo, Ronald P. ;
Fong, Yuman ;
Schwartz, Lawrence ;
Kemeny, Nancy ;
O'Reilly, Eileen ;
Abou-Alfa, Ghassan K. ;
Shimada, Hiroshi ;
Blumgart, Leslie H. ;
Jarnagin, William R. .
ANNALS OF SURGERY, 2008, 248 (01) :84-96
[5]   Intrahepatic Cholangiocarcinoma Primary Liver Resection and Aggressive Multimodal Treatment of Recurrence Significantly Prolong Survival [J].
Ercolani, Giorgio ;
Vetrone, Gaetano ;
Grazi, Gian Luca ;
Aramaki, Osamu ;
Cescon, Matteo ;
Ravaioli, Matteo ;
Serra, Carla ;
Brandi, Giovanni ;
Pinna, Antonio Daniele .
ANNALS OF SURGERY, 2010, 252 (01) :107-114
[6]   Influence of Surgical Margins on Outcome in Patients With Intrahepatic Cholangiocarcinoma A Multicenter Study by the AFC-IHCC-2009 Study Group [J].
Farges, Olivier ;
Fuks, David ;
Boleslawski, Emmanuel ;
Le Treut, Yves-Patrice ;
Castaing, Denis ;
Laurent, Alexis ;
Ducerf, Christian ;
Rivoire, Michel ;
Bachellier, Philippe ;
Chiche, Laurence ;
Nuzzo, Gennaro ;
Regimbeau, Jean Marc .
ANNALS OF SURGERY, 2011, 254 (05) :824-830
[7]   Patterns of Recurrence following Liver Resection for Intrahepatic Cholangiocarcinoma (IHC) and Recurrence Location Risk Score (RLRS) to Identify Patients Suitable for Loco-regional Treatment and Volumes of Interest [J].
Giuliante, F. ;
Ardito, F. ;
Mattiucci, G. C. ;
Barbaro, B. ;
De Rose, A. M. ;
Ranucci, G. ;
Manfrida, S. ;
Valentini, C. ;
Valentini, V. ;
Nuzzo, G. .
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2010, 78 (03) :S196-S196
[8]   Recurrence after operative management of intrahepatic cholangiocarcinoma [J].
Hyder, Omar ;
Hatzaras, Ioannis ;
Sotiropoulos, Georgios C. ;
Paul, Andreas ;
Alexandrescu, Sorin ;
Marques, Hugo ;
Pulitano, Carlo ;
Barroso, Eduardo ;
Clary, Bryan M. ;
Aldrighetti, Luca ;
Ferrone, Cristina R. ;
Zhu, Andrew X. ;
Bauer, Todd W. ;
Walters, Dustin M. ;
Groeschl, Ryan ;
Gamblin, T. Clark ;
Marsh, J. Wallis ;
Nguyen, Kevin T. ;
Turley, Ryan ;
Popescu, Irinel ;
Hubert, Catherine ;
Meyer, Stephanie ;
Choti, Michael A. ;
Gigot, Jean-Francois ;
Mentha, Gilles ;
Pawlik, Timothy M. .
SURGERY, 2013, 153 (06) :811-818
[9]   Pathogenesis, Diagnosis, and Management of Cholangiocarcinoma [J].
Ilyas, Sumera I. ;
Gores, Gregory J. .
GASTROENTEROLOGY, 2013, 145 (06) :1215-1229
[10]   Epidemiology, risk factors, and pathogenesis of cholangiocarcinoma [J].
Khan, S. A. ;
Toledano, M. B. ;
Taylor-Robinson, S. D. .
HPB, 2008, 10 (02) :77-82